Funders › CT › Rett Syndrome Research Trust Inc › 2018
Grants paid by Rett Syndrome Research Trust Inc, tax year 2018
EIN 26-0687439 · Trumbull, CT · Form 990, Schedule I · NTEE E12
In tax year 2018, Rett Syndrome Research Trust Inc (EIN 26-0687439) reported 18 grants paid totaling $7,166,943. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2018
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2018 | Gene Therapy Consortium | U | $1,800,098 | paid | GENE THERAPY CONSORTIUM | 201911349349301611 |
| 2018 | Ombd Consortium | U | $1,328,615 | paid | OMBD CONSORTIUM | 201911349349301611 |
| 2018 | Mecp2 Consortium | U | $778,719 | paid | MECP2 CONSORTIUM | 201911349349301611 |
| 2018 | Clinical Trial Consortium | U | $755,195 | paid | CLINICAL TRIAL CONSORTIUM | 201911349349301611 |
| 2018 | Q-State Biosciences Inc Cambridge, MA | A | $553,967 | paid | DRUG TESTING AND SCREENING | 201911349349301611 |
| 2018 | University of California at San Diego La Jolla, CA | A | $333,668 | paid | IDENTIFICATION OF MODIFIER GENES THAT SUPPRESS THE EFFECTS OF MECP2 MUTATIONS | 201911349349301611 |
| 2018 | Fred Hutchinson Cancer Research Center Seattle, WA | A | $285,465 | paid | REACTIVATING SILENT MECP2BNT CONFIRMATION | 201911349349301611 |
| 2018 | Whitehead Institute of Biomedical Research Cambridge, MA | A | $259,950 | paid | DRUG TESTING | 201911349349301611 |
| 2018 | Harvard University Boston, MA | A | $255,618 | paid | REACTIVATING SILENT MECP2DRUG SCREENINGMECP2 FUNCTION | 201911349349301611 |
| 2018 | Baylor College of Medicine Houston, TX | A | $242,702 | paid | PRECLINICAL DRUG DEVELOPMENT | 201911349349301611 |
| 2018 | University of Rochester Rochester, NY | A | $181,404 | paid | GENE THERAPY CONSORTIUMDRUG SCREEN | 201911349349301611 |
| 2018 | Nationwide Children's Hospital Columbus, OH | A | $101,659 | paid | GENE THERAPY CONSORTIUM | 201911349349301611 |
| 2018 | Case Western Reserve University Cleveland, OH | A | $84,146 | paid | PRE-CLINICAL TESTING OF COMPOUNDS | 201911349349301611 |
| 2018 | Rett Syndrome Center at Montefiore Medical Center Bronx, NY | A | $75,000 | paid | COPAXONE SUPPLEMENT | 201911349349301611 |
| 2018 | University of North Carolina Chapel Hill, NC | A | $74,487 | paid | GENE THERAPY CONSORTIUMDRUG SCREEN | 201911349349301611 |
| 2018 | Oregon Health and Sciences University Foundation Portland, OR | A | $28,750 | paid | MECP2 CONSORTIUM | 201911349349301611 |
| 2018 | Autism Science Foundation New York, NY | A | $17,500 | paid | GENETIC TESTING | 201911349349301611 |
| 2018 | Washington State University Pullman, WA | A | $10,000 | paid | GENE THERAPY CONSORTIUMDRUG SCREEN | 201911349349301611 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.